title: Acarbose improves glycemic control and reduces body weight: Subanalysis data of South Asia region.
abstract: Alpha-glucosidase inhibitors (AGIs) are widely used especially in Asian countries as a treatment option for type 2 diabetes patients with high postprandial glycaemia. However, data from South Asia region is very limited. In order to examine the effect of AGI in real-life setting, 10 PMS/NIS from all over the world from the launch of acarbose to date were pooled in one database and exploratory analysis was performed for glycemic parameters and weight. In total 62,905 patients were pooled from 21 countries and regions. Mean follow up (± SD) was 12.2 ± 4.8 weeks (range 0.1-108.9). From South Asia region (India and Pakistan), 8,738 Asian patients were enrolled. Mean PPG decreased from 240.0 and 261.1 mg/dl at baseline by 70.26 ± 65.10 and 82.96 ± 56.59 mg/dl at the last visit in total and South Asian populations, respectively (n = 53,883; n = 7,991, P < 0.0001 for both). Mean FPG decreased from 171.6 and 176.5 mg/dl at baseline by 38.48 ± 47.83 and 49.59 ± 41.41 mg/dl at the last visit in total and South Asian populations, respectively (n = 56,672; n = 7,837, P < 0.0001 for both). Mean HbA1c decreased from 8.4 and 8.4% at baseline by 1.11 ± 1.31% and 0.91 ± 0.93% at the last visit in total and South Asian populations, respectively (n = 38,843; n = 2,343, P < 0.0001 for both). Mean relative reduction of body weight (BW) was 1.40 ± 3.28% and 1.10 ± 3.39% at the last visit for mean baseline BW 73.6 and 74.2 kg in total and South Asian populations, respectively (n = 54,760; n = 7,718, P < 0.0001 for both). Consistent with RCT meta-analyses, post-hoc analysis of real-life data showed acarbose treatment improved glycaemic control and reduced the BW. Acarbose treatment in real life setting showed significant reductions in all glycemic parameters and BW in Asian patients from South Asia region.
authors.affiliation: Bharti Research Institute of Diabetes and Endocrinology Bharti Hospital, Department of Endocrinology, Karnal, India.
authors.forename: S
authors.initials: S
authors.lastname: Kalra
authors.forename: R K
authors.initials: RK
authors.lastname: Sahay
authors.forename: O
authors.initials: O
authors.lastname: Schnell
authors.forename: W H H
authors.initials: WH
authors.lastname: Sheu
authors.forename: W
authors.initials: W
authors.lastname: Grzeszczak
authors.forename: H
authors.initials: H
authors.lastname: Watada
authors.forename: S
authors.initials: S
authors.lastname: Soegondo
authors.forename: N
authors.initials: N
authors.lastname: Yamamoto
authors.forename: J
authors.initials: J
authors.lastname: Weng
authors.forename: R
authors.initials: R
authors.lastname: Rathod
keywords: Acarbose; South Asia; diabetes type-2